Anders Boss

1.5k total citations
35 papers, 872 citations indexed

About

Anders Boss is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anders Boss has authored 35 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anders Boss's work include Diabetes Management and Research (20 papers), Diabetes Treatment and Management (13 papers) and Inhalation and Respiratory Drug Delivery (10 papers). Anders Boss is often cited by papers focused on Diabetes Management and Research (20 papers), Diabetes Treatment and Management (13 papers) and Inhalation and Respiratory Drug Delivery (10 papers). Anders Boss collaborates with scholars based in United States, Germany and United Kingdom. Anders Boss's co-authors include Peter Richardson, Klaus Rave, Richard Petrucci, Lutz Heinemann, Tim Heise, R Baughman, Daniel Lorber, Marcus Hompesch, Mark T. Marino and Diane Costello and has published in prestigious journals such as The Lancet, Diabetes Care and Diabetes.

In The Last Decade

Anders Boss

34 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Boss United States 18 479 326 244 111 102 35 872
Klaus Rave Germany 22 1.3k 2.7× 385 1.2× 713 2.9× 153 1.4× 362 3.5× 44 1.8k
Manfred Wargenau Germany 13 151 0.3× 72 0.2× 144 0.6× 58 0.5× 15 0.1× 34 669
E Wahlin‐Boll Sweden 14 220 0.5× 209 0.6× 99 0.4× 50 0.5× 18 0.2× 34 707
Robert M. Stote United States 14 93 0.2× 118 0.4× 107 0.4× 77 0.7× 22 0.2× 25 702
Nicole Vaccaro United States 17 619 1.3× 83 0.3× 408 1.7× 38 0.3× 37 0.4× 25 945
M. Rongier France 18 91 0.2× 133 0.4× 118 0.5× 80 0.7× 31 0.3× 36 1.0k
B. Scherst�n Sweden 11 272 0.6× 19 0.1× 148 0.6× 50 0.5× 126 1.2× 12 499
Ganapathi Bantwal India 13 669 1.4× 25 0.1× 193 0.8× 48 0.4× 127 1.2× 64 987
Petr Bachleda Czechia 17 38 0.1× 277 0.8× 241 1.0× 79 0.7× 36 0.4× 91 837
A. D. B. Harrower United Kingdom 14 374 0.8× 20 0.1× 123 0.5× 29 0.3× 40 0.4× 44 710

Countries citing papers authored by Anders Boss

Since Specialization
Citations

This map shows the geographic impact of Anders Boss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Boss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Boss more than expected).

Fields of papers citing papers by Anders Boss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Boss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Boss. The network helps show where Anders Boss may publish in the future.

Co-authorship network of co-authors of Anders Boss

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Boss. A scholar is included among the top collaborators of Anders Boss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Boss. Anders Boss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCrimmon, Rory J., Philip Home, Alice Cheng, et al.. (2021). 1-LB: Advancing Therapy in Basal Insulin Users with Type 2 Diabetes (T2D): Hypoglycemia as a Function of HbA1c in the SoliMix Trial. Diabetes. 70(Supplement_1). 1 indexed citations
2.
3.
Hersi, Mona, Samuel Seidu, Kamlesh Khunti, et al.. (2020). PA2 Treatment Intensification and Risk of Cardiovascular Events in Insulin-Treated Patients with Type 2 Diabetes; A United Kingdom Retrospective Cohort Study. Value in Health. 23. S408–S408. 1 indexed citations
4.
5.
Peng, Xuejun, Rory J. McCrimmon, Leah Shepherd, et al.. (2020). Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study. Diabetes Therapy. 11(11). 2629–2645. 16 indexed citations
6.
Blonde, Lawrence, Luigi Meneghini, Xuejun Peng, et al.. (2018). Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA. Diabetes Therapy. 9(3). 1347–1358. 51 indexed citations
7.
Sambamoorthi, Usha, et al.. (2017). Persistence with rapid-acting insulin and its association with A1C level and severe hypoglycemia among elderly patients with type 2 diabetes. Current Medical Research and Opinion. 33(7). 1309–1316. 6 indexed citations
8.
Heinemann, Lutz, R Baughman, Anders Boss, & Marcus Hompesch. (2016). Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin. Journal of Diabetes Science and Technology. 11(1). 148–156. 55 indexed citations
9.
Visentin, R., Robert De Jager, Raphael Dahmen, et al.. (2016). Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator. Diabetes Technology & Therapeutics. 18(9). 574–585. 30 indexed citations
10.
Zisser, Howard, et al.. (2012). Technosphere Insulin Effectively Controls Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics. 14(11). 997–1001. 12 indexed citations
11.
Merten, Caroline, Martine Bakker, Anders Boss, et al.. (2011). Methodological characteristics of the national dietary surveys carried out in the European Union as included in the European Food Safety Authority (EFSA) Comprehensive European Food Consumption Database. Food Additives & Contaminants Part A. 28(8). 975–995. 71 indexed citations
12.
Raskin, P., Simon Heller, Miikka‐Juhani Honka, et al.. (2011). Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial. Diabetes Obesity and Metabolism. 14(2). 163–173. 46 indexed citations
13.
Rosenstock, Julio, Daniel L. Lorber, Luigi Gnudi, et al.. (2010). Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial. The Lancet. 375(9733). 2244–2253. 88 indexed citations
14.
Marino, Mark T., Diane Costello, R Baughman, et al.. (2010). Pharmacokinetics and Pharmacodynamics of Inhaled GLP-1 (MKC253): Proof-of-Concept Studies in Healthy Normal Volunteers and in Patients With Type 2 Diabetes. Clinical Pharmacology & Therapeutics. 88(2). 243–250. 30 indexed citations
15.
Marino, Mark T., James Cassidy, R Baughman, Anders Boss, & Peter Richardson. (2010). A new C‐peptide correction model used to assess bioavailability of regular human insulin. Biopharmaceutics & Drug Disposition. 31(7). 428–435. 2 indexed citations
16.
Hovorka, Roman, et al.. (2009). Technosphere insulin suppresses endogenous glucose production earlier than a rapid-acting analogue (lispro) and an inhaled insulin (Exubera (R)). View. 3 indexed citations
17.
Rave, Klaus, et al.. (2009). Pharmacokinetics and linear exposure of AFRESA™ compared with the subcutaneous injection of regular human insulin. Diabetes Obesity and Metabolism. 11(7). 715–720. 61 indexed citations
18.
Rosenson, Robert S., David Wolff, David Green, Anders Boss, & Kenneth R. Kensey. (2004). Aspirin. Journal of Thrombosis and Haemostasis. 2(2). 335–341. 11 indexed citations
19.
Wang, Sihe, Anders Boss, Kenneth R. Kensey, & Robert S. Rosenson. (2003). Variations of whole blood viscosity using Rheolog™—a new scanning capillary viscometer. Clinica Chimica Acta. 332(1-2). 79–82. 28 indexed citations
20.
Brooks, Andrew & Anders Boss. (1989). Safe changeover to Human Protaphane from porcine Semitard MC insulin. Practical Diabetes International. 6(2). 74–75. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klaus Rave Breakdown of academic impact, for papers by Manfred Wargenau Breakdown of academic impact, for papers by E Wahlin‐Boll Breakdown of academic impact, for papers by Robert M. Stote Breakdown of academic impact, for papers by Nicole Vaccaro Breakdown of academic impact, for papers by M. Rongier Breakdown of academic impact, for papers by B. Scherst�n Breakdown of academic impact, for papers by Ganapathi Bantwal Breakdown of academic impact, for papers by Petr Bachleda Breakdown of academic impact, for papers by A. D. B. Harrower
Rankless by CCL
2026